Abbott (ABT) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 01/22/26
Abbott Tumbles On Disappointing Fourth Quarter As Exact Closing LoomsInvestors Business Daily • 01/22/26
Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial OutlookPRNewsWire • 01/22/26
Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?Zacks Investment Research • 01/21/26
Polen Focus Growth Portfolio Q4 2025 Performance, Attribution & Portfolio ActivitySeeking Alpha • 01/21/26
Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythmsPRNewsWire • 01/20/26
Will Robust Adult Nutrition Business Performance Fuel ABT's Q4 Earnings?Zacks Investment Research • 01/19/26
Abbott (ABT) Declines More Than Market: Some Information for InvestorsZacks Investment Research • 01/16/26
Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXASPRNewsWire • 01/16/26
Insights Into Abbott (ABT) Q4: Wall Street Projections for Key MetricsZacks Investment Research • 01/16/26
Dividend King Abbott Shows Why 52 Consecutive Increases Weren't Luck With Strong Cash Flow Coverage24/7 Wall Street • 01/15/26
The Dividend Aristocrats No One's Talking About (And Their 30+ Year Track Records)24/7 Wall Street • 01/08/26
Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio StrategyAccesswire • 01/07/26